Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» KSQ Therapeutics
KSQ Therapeutics
Roche finds USP in cancer, inking deal with KSQ to expand stable of synthetic lethal candidates
Fierce Biotech
Thu, 07/13/23 - 11:36 am
Roche
KSQ Therapeutics
synthetic lethality
Takeda puts $510M on the line to expand KSQ cancer collaboration
Fierce Biotech
Wed, 05/17/23 - 10:09 am
Takeda
KSQ Therapeutics
cancer
oncology
KSQ boosts PARP inhibition in animal models of ovarian and breast cancers with USP1 inhibitor
Fierce Biotech
Sun, 10/25/20 - 11:28 pm
KSQ Therapeutics
PARP inhibitors
ovarian cancer
breast cancer
KSQ-4279
Merck
AstraZeneca
Lynparza
KSQ Therapeutics Banks $80 Million in Series C Round
CP Wire
Fri, 09/28/18 - 11:57 am
KSQ Therapeutics
KSQ Therapeutics Banks $80 Million in Series C Round
Fri, 09/28/18 - 11:56 am
KSQ Therapeutics